Skip to content

Dynamic Myocardial Perfusion Imaging by 320 Multidetector Computed Tomography

Dynamic Myocardial Perfusion Imaging by 320 Multidetector Computed Tomography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01368237
Enrollment
51
Registered
2011-06-07
Start date
2006-05-31
Completion date
2017-01-01
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Keywords

Computed tomography, Myocardial perfusion, Coronary heart disease

Brief summary

Recent advances in technology have resulted in the development of scanners that can image the heart blood vessels within 10 to 20 minutes but without the need for admission to hospital or insertion of catheters. Further advances in technology allow the visualisation of both the blood vessels and the supply of blood to the heart muscle. Here we propose to assess the latest and most powerful computed tomography scanner and compare it to magnetic resonance and conventional coronary angiography.

Interventions

Computed tomography will be performed using a 320 multidetector computed tomography scanner and may include coronary calcium score, coronary angiography and imaging of myocardial perfusion, function and viability.

Sponsors

NHS Lothian
CollaboratorOTHER_GOV
University of Edinburgh
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* referred for invasive coronary angiography because of suspected coronary heart disease

Exclusion criteria

* inability or unwillingness to undergo computed tomography or magnetic resonance imaging * renal failure (serum creatinine \>200 micromol/L or estimated glomerular filtration rate \<30 mL/min) * hepatic failure * allergy to iodinated contrast or gadolinium * pregnancy * contraindication to adenosine infusion * inability to give informed consent * inability to perform fractional flow reserve during invasive coronary angiography

Design outcomes

Primary

MeasureTime frameDescription
Myocardial perfusion defects defined qualitatively by trained observers and quantitatively by computer software1 monthThe primary outcome measure is to establish whether 320-multidetector computed tomography can identify myocardial perfusion defects as compared to the gold standards of 3Tesla magnetic resonance imaging and fractional flow reserve measured during invasive coronary angiography.

Secondary

MeasureTime frameDescription
Identification of regional wall motion abnormalities qualitatively by trained observers1 monthOur secondary outcome measures are to assess the performance of 320-multidetector computed tomography in the detection of regional wall motion abnormalities in comparison to those obtained with 3Tesla cardiac magnetic resonance imaging.
Identification of infarction qualitatively by trained observers1 monthOur secondary outcome measures are to assess the performance of 320-multidetector computed tomography in the detection of infarction in comparison to those obtained with 3Tesla cardiac magnetic resonance imaging.
Identification of regional wall motion abnormalities quantitatively by computer software1 monthOur secondary outcome measures are to assess the performance of 320-multidetector computed tomography in the detection of regional wall motion abnormalities in comparison to those obtained with 3Tesla cardiac magnetic resonance imaging.
Identification of infarction qualitatively by computer software1 monthOur secondary outcome measures are to assess the performance of 320-multidetector computed tomography in the detection of infarction in comparison to those obtained with 3Tesla cardiac magnetic resonance imaging.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026